Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
Pharmalot
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Pharma deploys its top guns to Capitol Hill as senators mull drug pricing package

  • Lev Facher
  • Nicholas Florko
  • Andrew Joseph

By Lev Facher , Nicholas Florko and Andrew Joseph July 17, 2019

Reprints
Ubl
PhRMA CEO Steve Ubl Matt Rourke/AP

WASHINGTON — The pharmaceutical industry deployed its top guns to Capitol Hill on Wednesday as senators pushed to find consensus on a major package of drug pricing reforms.

Spotted in the Senate basement at lunchtime: Stephen Ubl, the head of the industry lobbying organization PhRMA, and Dr. Giovanni Caforio, the CEO of Bristol Myers-Squibb.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Lev Facher

Lev Facher

Addiction Reporter

Lev Facher covers the U.S. addiction and overdose crisis.

Nicholas Florko

Nicholas Florko

Commercial Determinants of Health Reporter

Nicholas Florko reports on the commercial determinants of health. He is the author the newsletter "D.C. Diagnosis."

Andrew Joseph

Andrew Joseph

General Assignment Reporter

Andrew covers a range of topics, from addiction to public health to genetics.

Tags

A complicated fall vaccine campaign: Updated Covid boosters, flu…
A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs
Bright Health Group heads toward insolvency as it rushes…
Bright Health Group heads toward insolvency as it rushes to raise more cash
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Blueprint Medicines drug reduces mastocytosis symptoms in a new…
Blueprint Medicines drug reduces mastocytosis symptoms in a new study, meeting investor expectations
Ex-Google CEO’s VC firm brings in hype-busting researcher to…
Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments
Hospital mergers that dodge antitrust scrutiny lead to dramatically…
Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds

Recommended Stories